Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis
2023-01-01 Gramegna, Andrea; Misuraca, Sofia; Lombardi, Andrea; Premuda, Chiara; Barone, Ivan; Ori, Margherita; Amati, Francesco; Retucci, Mariangela; Nazzari, Erica; Alicandro, Gianfranco; Ferrarese, Maurizio; Codecasa, Luigi; Bandera, Alessandra; Aliberti, Stefano; Daccò, Valeria; Blasi, Francesco
Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections
2023-01-01 Cavalli, Carolina Aliai Micol; Gabbiadini, Roberto; Dal Buono, Arianna; Quadarella, Alessandro; De Marco, Alessandro; Repici, Alessandro; Bezzio, Cristina; Simonetta, Edoardo; Aliberti, Stefano; Armuzzi, Alessandro
Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations
2021-01-01 Vespa, Edoardo; Pugliese, Nicola; Colapietro, Francesca; Aghemo, Alessio
Videomics: bringing deep learning to diagnostic endoscopy
2021-01-01 Paderno, A; Holsinger, Fc; Piazza, C
Best Practice in Surgical Treatment of Malignant Head and Neck Tumors
2020-01-01 Simon, C; Nicolai, P; Paderno, A; Dietz, A
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment
2021-01-01 Virga, Federico; Quirico, Lorena; Cucinelli, Stefania; Mazzone, Massimiliano; Taverna, Daniela; Orso, Francesca
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives
2021-01-01 Giustozzi, A; Salutari, V; Giudice, E; Musacchio, L; Ricci, C; Landolfo, C; Perri, Mt; Scambia, G; Lorusso, D
Managing recurrent ovarian cancer in daily clinical practice: case studies and evidence review with a focus on the use of trabectedin
2021-01-01 Lorusso, D; González-Martín, A; Ray-Coquard, I
The Role of Artificial Intelligence in Managing Multimorbidity and Cancer
2021-01-01 Cesario, A; D'Oria, M; Calvani, R; Picca, A; Pietragalla, A; Lorusso, D; Daniele, G; Lohmeyer, Fm; Boldrini, L; Valentini, V; Bernabei, R; Auffray, C; Scambia, G
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine
2021-01-01 Nero, C; Vizzielli, G; Lorusso, D; Cesari, E; Daniele, G; Loverro, M; Scambia, G; Sette, C
Management of stage III and IVa uterine cancer
2022-01-01 Nero, C; Tronconi, F; Giudice, E; Scambia, G; Lorusso, D
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data
2021-01-01 Duranti, S; Pietragalla, A; Daniele, G; Nero, C; Ciccarone, F; Scambia, G; Lorusso, D
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
2021-01-01 Concin, N; Matias-Guiu, X; Vergote, I; Cibula, D; Mirza, Mr; Marnitz, S; Ledermann, J; Bosse, T; Chargari, C; Fagotti, A; Fotopoulou, C; Gonzalez Martin, A; Lax, S; Lorusso, D; Marth, C; Morice, P; Nout, Ra; O'Donnell, D; Querleu, D; Raspollini, Mr; Sehouli, J; Sturdza, A; Taylor, A; Westermann, A; Wimberger, P; Colombo, N; Planchamp, F; Creutzberg, Cl
Progress in the management of endometrial cancer (subtypes, immunotherapy, alterations in PIK3CA pathway): data and perspectives
2020-01-01 Oaknin, A; León-Castillo, A; Lorusso, D
Uterine serous carcinoma
2021-01-01 Bogani, G; Ray-Coquard, I; Concin, N; Ngoi, Nyl; Morice, P; Enomoto, T; Takehara, K; Denys, H; Nout, Ra; Lorusso, D; Vaughan, Mm; Bini, M; Takano, M; Provencher, D; Indini, A; Sagae, S; Wimberger, P; Póka, R; Segev, Y; Kim, Si; Candido Dos Reis, Fj; Lopez, S; Mariani, A; Leitao, Mm; Raspagliesi, F; Panici Benedetti, P; Di Donato, V; Muzii, L; Colombo, N; Scambia, G; Pignata, S; Monk, Bj
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives
2022-01-01 Musacchio, L; Cicala, Cm; Salutari, V; Camarda, F; Carbone, Mv; Ghizzoni, V; Giudice, E; Nero, C; Perri, Mt; Ricci, C; Tronconi, F; Scambia, G; Lorusso, D
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?
2020-01-01 Lorusso, D; Ray-Coquard, I; Oaknin, A; Banerjee, S
Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM)
2021-01-01 Gadducci, A; Aletti, Gd; Landoni, F; Lazzari, R; Mangili, G; Olivas, P; Pignata, S; Salutari, V; Sartori, E; Scambia, G; Zannoni, Gf; Sabbatini, R; Lorusso, D
Will68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update
2018-01-01 Cuccurullo, V.; di Stasio, G. D.; Evangelista, L.; Ciarmiello, A.; Mansi, L.
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine
2019-01-01 Carpanese, D.; Zorz, A.; Evangelista, L.; Salvarese, N.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis | 1-gen-2023 | Gramegna, Andrea; Misuraca, Sofia; Lombardi, Andrea; Premuda, Chiara; Barone, Ivan; Ori, Margherita; Amati, Francesco; Retucci, Mariangela; Nazzari, Erica; Alicandro, Gianfranco; Ferrarese, Maurizio; Codecasa, Luigi; Bandera, Alessandra; Aliberti, Stefano; Daccò, Valeria; Blasi, Francesco | |
Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections | 1-gen-2023 | Cavalli, Carolina Aliai Micol; Gabbiadini, Roberto; Dal Buono, Arianna; Quadarella, Alessandro; De Marco, Alessandro; Repici, Alessandro; Bezzio, Cristina; Simonetta, Edoardo; Aliberti, Stefano; Armuzzi, Alessandro | |
Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations | 1-gen-2021 | Vespa, Edoardo; Pugliese, Nicola; Colapietro, Francesca; Aghemo, Alessio | |
Videomics: bringing deep learning to diagnostic endoscopy | 1-gen-2021 | Paderno, A; Holsinger, Fc; Piazza, C | |
Best Practice in Surgical Treatment of Malignant Head and Neck Tumors | 1-gen-2020 | Simon, C; Nicolai, P; Paderno, A; Dietz, A | |
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment | 1-gen-2021 | Virga, Federico; Quirico, Lorena; Cucinelli, Stefania; Mazzone, Massimiliano; Taverna, Daniela; Orso, Francesca | |
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives | 1-gen-2021 | Giustozzi, A; Salutari, V; Giudice, E; Musacchio, L; Ricci, C; Landolfo, C; Perri, Mt; Scambia, G; Lorusso, D | |
Managing recurrent ovarian cancer in daily clinical practice: case studies and evidence review with a focus on the use of trabectedin | 1-gen-2021 | Lorusso, D; González-Martín, A; Ray-Coquard, I | |
The Role of Artificial Intelligence in Managing Multimorbidity and Cancer | 1-gen-2021 | Cesario, A; D'Oria, M; Calvani, R; Picca, A; Pietragalla, A; Lorusso, D; Daniele, G; Lohmeyer, Fm; Boldrini, L; Valentini, V; Bernabei, R; Auffray, C; Scambia, G | |
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine | 1-gen-2021 | Nero, C; Vizzielli, G; Lorusso, D; Cesari, E; Daniele, G; Loverro, M; Scambia, G; Sette, C | |
Management of stage III and IVa uterine cancer | 1-gen-2022 | Nero, C; Tronconi, F; Giudice, E; Scambia, G; Lorusso, D | |
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data | 1-gen-2021 | Duranti, S; Pietragalla, A; Daniele, G; Nero, C; Ciccarone, F; Scambia, G; Lorusso, D | |
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma | 1-gen-2021 | Concin, N; Matias-Guiu, X; Vergote, I; Cibula, D; Mirza, Mr; Marnitz, S; Ledermann, J; Bosse, T; Chargari, C; Fagotti, A; Fotopoulou, C; Gonzalez Martin, A; Lax, S; Lorusso, D; Marth, C; Morice, P; Nout, Ra; O'Donnell, D; Querleu, D; Raspollini, Mr; Sehouli, J; Sturdza, A; Taylor, A; Westermann, A; Wimberger, P; Colombo, N; Planchamp, F; Creutzberg, Cl | |
Progress in the management of endometrial cancer (subtypes, immunotherapy, alterations in PIK3CA pathway): data and perspectives | 1-gen-2020 | Oaknin, A; León-Castillo, A; Lorusso, D | |
Uterine serous carcinoma | 1-gen-2021 | Bogani, G; Ray-Coquard, I; Concin, N; Ngoi, Nyl; Morice, P; Enomoto, T; Takehara, K; Denys, H; Nout, Ra; Lorusso, D; Vaughan, Mm; Bini, M; Takano, M; Provencher, D; Indini, A; Sagae, S; Wimberger, P; Póka, R; Segev, Y; Kim, Si; Candido Dos Reis, Fj; Lopez, S; Mariani, A; Leitao, Mm; Raspagliesi, F; Panici Benedetti, P; Di Donato, V; Muzii, L; Colombo, N; Scambia, G; Pignata, S; Monk, Bj | |
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives | 1-gen-2022 | Musacchio, L; Cicala, Cm; Salutari, V; Camarda, F; Carbone, Mv; Ghizzoni, V; Giudice, E; Nero, C; Perri, Mt; Ricci, C; Tronconi, F; Scambia, G; Lorusso, D | |
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change? | 1-gen-2020 | Lorusso, D; Ray-Coquard, I; Oaknin, A; Banerjee, S | |
Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM) | 1-gen-2021 | Gadducci, A; Aletti, Gd; Landoni, F; Lazzari, R; Mangili, G; Olivas, P; Pignata, S; Salutari, V; Sartori, E; Scambia, G; Zannoni, Gf; Sabbatini, R; Lorusso, D | |
Will68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update | 1-gen-2018 | Cuccurullo, V.; di Stasio, G. D.; Evangelista, L.; Ciarmiello, A.; Mansi, L. | |
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine | 1-gen-2019 | Carpanese, D.; Zorz, A.; Evangelista, L.; Salvarese, N. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista406
Data di pubblicazione
- 2020 - 2024255
- 2010 - 2019132
- 2000 - 200917
- 1990 - 19991
- 1985 - 19891
Rivista
- JOURNAL OF CLINICAL MEDICINE12
- DIGESTIVE AND LIVER DISEASE10
- CANCERS8
- CLINICAL AND TRANSLATIONAL IMAGING8
- FRONTIERS IN IMMUNOLOGY7
- FRONTIERS IN ONCOLOGY7
- CRITICAL REVIEWS IN ONCOLOGY HEMA...6
- DIAGNOSTICS6
- CANCER TREATMENT REVIEWS5
- CLINICAL GASTROENTEROLOGY AND HEP...5
Keyword
- Humans58
- Animals15
- inflammatory bowel disease13
- COVID-199
- Neoplasms8
- Male7
- PET/CT7
- Biomarkers6
- Cardiovascular Diseases6
- Crohn’s disease6
Lingua
- eng349
- ita3
- ger1
- spa1
Accesso al fulltext
- no fulltext392
- reserved10
- open4